小型中风,大影响:在帕金森病中急性缺血性中风后的过度死亡率
Lee E Neilson1,2,3, Chen Lin4,5, Anusha Mishra1
1Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA.
Movement disorders : official journal of the Movement Disorder Society
|February 10, 2026
概括
患有帕金森病 (PD) 和急性缺血性中风 (AIS) 的患者面临显著更高的死亡率. 这种增加的风险独立于其他健康状况,表明需要针对PD中风患者进行向治疗.
科学领域:
- 神经学 神经学
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 帕金森病 (PD) 患者的急性缺血性中风 (AIS) 是越来越大的公共卫生挑战.
- 关于这种特定患者群体的死亡率的研究有限.
研究的目的:
- 分析PD和AIS患者的短期和长期存活率.
- 根据并发症和中风特征对生存结果进行分层.
主要方法:
- 利用了来自美国退伍军人卫生管理局的数据.
- 使用验证的ICD代码和其他健康记录来定义AIS和PD.
- 匹配3173个PD+AIS病例 4:1与PD-only,中风-only和对照组进行10年生存分析.
- 对一组病例的中风特征 (大小,位置,机制) 进行了审查.
主要成果:
- 与PD单独,中风单独和对照组相比,PD+AIS患者的死亡率明显较高.
- 这种增加的死亡率在0-1,1-5年和5-10年期间显示出明显的模式,表明了协同效应.
- 即使考虑到心血管并发症,神经创伤和虚弱,这种高风险仍然存在.
- 患有PD+AIS的患者往往比仅患有中风的患者中风较小,其位置,机制和复发率相似.
结论:
- 患有PD和AIS的患者经历的死亡率大于预期,不论是并发症或中风细节.
- 这一发现表明PD患者的潜在系统缺陷加剧了中风的结果.
- 在患有帕金森病的个体中,可能需要专门的治疗方法来管理AIS.
相关概念视频
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:15Ischemic Stroke ll: Pathophysiology
68
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
68
01:29Hemorrhagic Stroke ll: Pathophysiology
52
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
52
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:24Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34